← All trials
NCT00785421
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2004
- Primary completion
- Jan 1, 2009
- Completion date
- Jun 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 312
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- CONKO Study GroupLead sponsor
- CONKO Study GroupStudy director
- SanofiCollaborator
- AmgenCollaborator
- Eli LillyCollaborator
- CONKO Study GroupReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.